다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

MDGL Madrigal Pharmaceuticals Inc

302.67

0.00 (0.00%)

시간외 단일가

최종 업데이트: 18:05:33

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

09/10/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ William John Sibold

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Madrigal Pharmaceuticals (NASDAQ:MDGL)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024

Madrigal Pharmaceuticals 차트를 더 보려면 여기를 클릭.

Madrigal Pharmaceuticals (NASDAQ:MDGL)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024

Madrigal Pharmaceuticals 차트를 더 보려면 여기를 클릭.

Madrigal Pharmaceuticals Inc News

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
0년 15월 11일, 2024 (12 시간 전) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
0년 14월 11일, 2024 (22 시간 전) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
0년 9월 11일, 2024 (6 일 전) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
0년 8월 11일, 2024 (1 주 전) • Edgar (US Regulatory)

Madrigal Pharmaceuticals, Inc. Announces Participation at Three Upcoming Investor Conferences
0년 6월 11일, 2024 (1 주 전) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
0년 6월 11일, 2024 (1 주 전) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
0년 2월 11일, 2024 (2 주 전) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
0년 1월 11일, 2024 (2 주 전) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
0년 31월 10일, 2024 (2 주 전) • Edgar (US Regulatory)

Form 8-K - Current report
0년 31월 10일, 2024 (2 주 전) • Edgar (US Regulatory)

Madrigal Pharmaceuticals Reports Third-Quarter 2024 Financial Results and Provides Corporate Updates
0년 31월 10일, 2024 (2 주 전) • GlobeNewswire Inc.

Madrigal Pharmaceuticals to Present Multiple Rezdiffra™ (resmetirom) Abstracts in NASH/MASH at the AASLD Liver Meeting®
0년 30월 10일, 2024 (2 주 전) • GlobeNewswire Inc.

More Madrigal Pharmaceuticals Inc News Articles

GoverMedia Plus Canada

Banca Popolare di Sondrio

Market Strength Allocati...

Global Partner Acqusitio...

Entourage Metals Ltd.

Danimer Scientific

Lulus Fashion Lounge

NLBNPIT1UT47 20991231 16...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관